Compare SELLAS Life Sciences Group Inc. Common Stock (SLS) vs Utilities Select Sector SPDR Fund (XLU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
SELLAS Life Sciences Group Inc. Common Stock vs Utilities Select Sector SPDR Fund — how do they compare? SELLAS Life Sciences Group Inc. Common Stock trades at $11.47 (market cap $2.27B), while Utilities Select Sector SPDR Fund trades at $41.21 (market cap $23.60B). The key difference: Utilities Select Sector SPDR Fund is far larger — about 10.4× SELLAS Life Sciences Group Inc. Common Stock's market cap, and SELLAS Life Sciences Group Inc. Common Stock is trading nearer its 52-week high, Utilities Select Sector SPDR Fund nearer its low. Which is the better fit depends on your goals.
| SLS | XLU | |
|---|---|---|
Market Cap | $2.27B | $23.60B |
Volume | 4,179,659 | 28,758,237 |
Sector | Health | — |
52-Week High | $15.46 | $47.73 |
52-Week Low | $1.39 | $39.25 |
Enterprise Value | $2.14B | — |
Typical Hold Time | — | 80 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
XLU trades at $41.09, down 0.15% with mixed technical signals showing a bullish moving average trend but neutral oscillators. The ETF recently hit 52-week lows amid sector-wide pressure from rising interest rates. Support levels cluster around $40-41 while resistance sits at $41-42. Recent news highlights utility stocks as oversold with potential defensive appeal during market volatility.
The outlook remains cautious given interest rate sensitivity, though current levels may offer value for defensive positioning. Key risks include further rate hikes and AI power demand uncertainty. Analyst sentiment is divided with technical indicators suggesting near-term consolidation potential.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →About Utilities Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes securities of companies from the following industries: electric utilities; water utilities; multi-utilities; independent power and renewable electricity producers; and gas utilities. The fund is non-diversified.
Read more on XLU →
